Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
As of today, Gilead Sciences(GILD) shares are valued at $147.32. The company's market cap stands at 183.07B, with a P/E ratio of -55.56 and a dividend yield of 2.24%.
As of 2026-08-19, Gilead Sciences(GILD) stock has fluctuated between $144.30 and $148.97. The current price stands at $147.32, placing the stock +2.1% above today's low and -1.1% off the high.
Gilead Sciences(GILD) shares are trading with a volume of 6.74M, against a daily average of 6.02M.
During the past year, Gilead Sciences(GILD) stock moved between $108.46 at its lowest and $157.29 at its peak.
During the past year, Gilead Sciences(GILD) stock moved between $108.46 at its lowest and $157.29 at its peak.
GILD News
Key Points The stocks on this list have strong underlying businesses that can do well, even during downturns. Walmart, McDonald's, and Gilead Sciences outperf...
...
Key Points Gilead has been quite active in acquisitions this year. The company saw double-digit revenue growth in the second quarter, led by HIV drug sales....
Analyst ratings
80%
of 30 ratingsMore GILD News
Gilead Sciences ((GILD)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with...
Nucleai recently announced an ongoing translational research collaboration with Gilead Sciences, using AI-powered tissue analytics to support Gilead’s global an...
Gilead Sciences (GILD) is back on investors’ radar after its new collaboration with Nucleai, which applies AI powered tissue analytics to antibody drug conjugat...
For many Americans, the price of prescription drugs is an enigma. One medication costs a few dollars, while another costs more than a mortgage. Running a pharm...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.